US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Glutamine 25 mg/mL

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0259-2017
Class II · Moderate risk Ongoing

Glucosamine 200 mg/mL

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0258-2017
Class II · Moderate risk Ongoing

Dexpanthenol 250 mg/mL

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0256-2017
Class II · Moderate risk Ongoing

Calm Me

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0255-2017
Class II · Moderate risk Ongoing

B-Complex

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0250-2017
Class II · Moderate risk Ongoing

Bcaa

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0249-2017
Class II · Moderate risk Ongoing

Ascorbic Acid 500 mg/mL

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0248-2017
Class II · Moderate risk Ongoing

Amino Acid Recover Eaze

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0247-2017
Class II · Moderate risk Ongoing

Amino Energy Cocktail

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0246-2017
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason Failed Stability Specifications; out-of specification value for homogeneity / phase separation.

Akorn Inc NDC 61748-206-15 D-0152-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial Contamination of Non-Sterile Products: bulk solution tested positive for the presence of the bacteria, Burkholderia cepacia.

VistaPharm, Inc. NDC 66689-039-01 D-0146-2017
Class II · Moderate risk Terminated

L-Cysteine Hydrochloride Injection

Reason Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Sandoz Inc NDC 66758-005-01 D-0141-2017
Class II · Moderate risk Terminated

L-Cysteine Hydrochloride Injection

Reason Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Sandoz Inc NDC 66758-004-01 D-0140-2017
Class II · Moderate risk Terminated

Levoxyl

Reason Superpotent

Pfizer Inc. NDC 60793-860-01 D-0150-2017
Class II · Moderate risk Terminated

Papa/Phen/Prost

Reason Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

Fallon Wellness Pharmacy, L.L.C. D-0174-2017
Class II · Moderate risk Terminated

Papa/Phen/Prost

Reason Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

Fallon Wellness Pharmacy, L.L.C. D-0173-2017
Class II · Moderate risk Terminated

Metformin Hydrochloride Tablets

Reason Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

Ascend Laboratories LLC NDC 67877-217-10 D-0163-2017
Class II · Moderate risk Terminated

Fentanyl Citrate Injection

Reason Lack of Assurance of Sterility: Complaints of broken tips on the ampules.

Hospira Inc. NDC 0409-4093-32 D-0153-2017
Class II · Moderate risk Terminated

Phenazopyridine Hydrochloride Tablets

Reason CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Nationwide Laboratories, LLC NDC 42937-702-10 D-0168-2017
Class II · Moderate risk Terminated

Phenazopyridine Hydrochloride Tablets

Reason CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Nationwide Laboratories, LLC NDC 42937-701-10 D-0167-2017